Opinion · 22 Oct 2024
ArticlePublished 2012
50. Development of Solid Self Micro Emulsifying Drug Delivery System with Neusilin US2 for Enhanced Dissolution Rate of Telmisartan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim of present study was to develop solid self micro emulsifying drug delivery system (S-SMEDDS) with Neusilin US2 for enhancement of dissolution rate of Telmisartan (TEL). SMEDDS was prepared using Oleic acid, Tween 80 and PEG 400 as oil, surfactant and cosurfactant respectively. For formulation of stable SMEDDS, micro emulsion region was identified by constructing pseudo ternary phase diagram containing different proportion of surfactant: co-surfactant (Km value 1:1, 2:1 and 3:1), oil and water. Prepared SMEDDS was evaluated for thermodynamic stability study, dispersibility tests, globule size and zeta potential. S-SMEDDS was prepared by adsorption technique using Neusilin US2 as solid carrier. Prepared S-SMEDDS was evaluated for flow properties, drug content, reconstitution properties, FTIR, SEM, DSC and in-vitro dissolution study. Results showed that prepared liquid SMEDDS passed dispersibility test with good thermodynamic stability. Globule size was found to be 30.2 nm with polydispersity index 0.116 and -5.80 mV zeta potential. S-SMEDDS showed good flow property and drug content. Reconstitution properties of S-SMEDDS showed spontaneous micro emulsification with globule size 32.4 nm and polydispersity index 0.219 and -6.32 mV zeta potential. Results of in-vitro dissolution showed that there was enhancement of dissolution rate of TEL as compared with that of plain TEL. From the results study concluded that, Neusilin US2 can be used to develop S-SMEDDS by adsorption technique to enhance dissolution rate of poorly water soluble drug such as TEL.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bhagwat Durgacharan A”
- BylineArticles whose byline prints “DSouza John I”
